PWMG
UTHR icon

Prestige Wealth Management Group’s United Therapeutics UTHR Stock Holding History

Prestige Wealth Management Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.59K Hold
14
– – ﹤0.01% 490
2026
Q1 		$8.3K Hold
14
– – ﹤0.01% 458
2025
Q4 		$6.82K Hold
14
– – ﹤0.01% 514
2025
Q3 		$5.87K Buy
14
+5
+56% +$1.68K ﹤0.01% 539
2025
Q2 		$2.59K Buy
9
+1
+13% +$299 ﹤0.01% 688
2025
Q1 		$2.47K Hold
8
– – ﹤0.01% 700
2024
Q4 		$2.82K Hold
8
– – ﹤0.01% 712
2024
Q3 		$2.87K Hold
8
– – ﹤0.01% 705
2024
Q2 		$2.55K Buy
8
+1
+14% +$265 ﹤0.01% 677
2024
Q1 		$1.61K Sell
7
-22
-76% -$4.96K ﹤0.01% 791
2023
Q4 		$6.38K Hold
29
– – ﹤0.01% 541
2023
Q3 		$6.55K Hold
29
– – ﹤0.01% 521
2023
Q2 		$6.4K Buy
29
+26
+867% +$5.76K ﹤0.01% 533
2023
Q1 		$672 Hold
3
– – ﹤0.01% 939
2022
Q4 		$834 Hold
3
– – ﹤0.01% 1003
2022
Q3 		$1K Hold
3
– – ﹤0.01% 931
2022
Q2 		$1K Hold
3
– – ﹤0.01% 936
2022
Q1 		$1K Hold
3
– – ﹤0.01% 941
2021
Q4 		$1K Hold
3
– – ﹤0.01% 960
2021
Q3 		$1K Hold
3
– – ﹤0.01% 945
2021
Q2 		$1K Hold
3
– – ﹤0.01% 935
2021
Q1 		$1K Hold
3
– – ﹤0.01% 920
2020
Q4 		$0 Hold
3
– – ﹤0.01% 1043
2020
Q3 		$0 Hold
3
– – ﹤0.01% 924
2020
Q2 		$0 Hold
3
– – ﹤0.01% 963
2020
Q1 		$0 Buy
+3
New +$285 ﹤0.01% 1010
2019
Q3 		– Sell
-3,058
Closed -$238K – 644
2019
Q2 		$238K Sell
3,058
-2,103
-41% -$197K 0.14% 102
2019
Q1 		$606K Buy
5,161
+1,218
+31% +$142K 0.37% 48
2018
Q4 		$429K Buy
+3,943
New +$457K 0.32% 62

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Prestige Wealth Management Group's UTHR Position: Q2 2026 in Review

Prestige Wealth Management Group held its United Therapeutics (UTHR) position steady in Q2 2026 at 14 shares worth $7.59K. The position accounts for ﹤0.01% of the portfolio, ranked #490.

Prestige Wealth Management Group first reported a position in UTHR in Q4 2018 and has held it in 29 quarters since. The position peaked at $606K in Q1 2019. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Prestige Wealth Management Group held 14 shares of United Therapeutics worth $7.59K as of Q2 2026.
  • Prestige Wealth Management Group left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Prestige Wealth Management Group's portfolio in Q2 2026, its #490 holding.
  • Prestige Wealth Management Group first reported a position in United Therapeutics in Q4 2018 and has held it in 29 quarters since.
  • Prestige Wealth Management Group's United Therapeutics position peaked at $606K in Q1 2019.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.